Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-08 Purchase(A) |
2023-02-17 6:40 pm |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
27,000 | $1.8929 | $51,108 | 435,514 (Indirect) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:25 pm |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
27,000 | $1.8929 | $51,108 | 152,000 (Direct) |
View |
| 2021-07-29 Purchase |
2021-08-02 8:12 pm |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
125,000 | $8 | $1,000,000 | 125,000 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-26 Option Award |
2024-06-27 08:39 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2022-10-13 Option Award |
2022-10-17 4:42 pm |
N/A 2032-10-13 |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2021-07-29 Conversion |
2021-08-02 8:12 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
980,365 | $0 | 125,000 (Indirect) |
View |
Ownership |
2021-07-26 9:20 pm |
N/A 2030-12-29 |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
0 | $0 | 599,576 (Direct) |
View |